3 ms·
The issue is that they’d then have to pay for preclinical studies to determine safety, which would add millions of dollars to the budget. Whereas for psilocybin
by Alex3917 5y ago
The issue is that they’d then have to pay for preclinical studies to determine safety, which would add millions of dollars to the budget. Whereas for psilocybin that work was largely done decades ago.
- qwerty456127 5y agoNice point. By the way, IMO, some long-known and safe substances should also be given new tries in combination with the researched psychedelics. E.g. I believe piracetam is a great thing to take half an hour before you take MDMA - it may catalyse the effect (in a therapeutic setting especially as speaking boost is among its effects) and prevent hangover. It's not approved by the FDA but widely used in Europe and obviously (given a really huge base of empiric evidence) safe.